Morgan Stanley lowered shares of Intellia Therapeutics (NASDAQ:NTLA – Free Report) from an overweight rating to an equal ...

Pomerantz LLP is investigating claims on behalf of investors of Intellia Therapeutics, Inc. ("Intellia" or the "Company") . Such investors are advised to contact Danielle Peyton at ...

The Nature Conservancy (TNC) recently announced the successful completion of its Human:Nature campaign, the largest fundraising initiative for conservation in Indiana's history. Built on the belief ...

Analysts have set 12-month price targets for Regeneron Pharmaceuticals, revealing an average target of $945.56, a high ...

Cell Therapy Regenerative medicine Market. The Cell Therapy Regenerative Medicine market is poised for significant growth, driven by advancements in techno ...

Citi analyst Geoff Meacham lowered the firm’s price target on Pfizer (PFE) to $29 from $30 and keeps a Neutral rating on the shares. Ahead of ...

Metro Inc (MRU.T,MTRAF) is expected to report $1.06 for 1Q. NVR Inc (NVR) is expected to report $129.87 for 4Q. Paccar Inc (PCAR) is expected to report $1.69 for 4Q. Peoples Bancorp of North Carolina ...